Article

High expression of JAM2 indicates better prognosis and immunotherapy response in breast cancer

2020-12-11

Abstract excerpt

In our study, multiple databases were used to explore the potential role and underlying mechanism of junctional adhesion molecule B (JAM2) in breast cancer (BRCA). The data of JAM2 was downloaded from The Cancer Cell Line Encyclopedia (CCLE), the Genotype-Tissue Expression (GTEx), The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) databases. Receiver operatin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 00db35ec-ce8e-5a79-8f36-c9d47412b799
DOI: 10.1101/2020.12.11.421081

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

High expression of JAM2 indicates better prognosis and immunotherapy response in breast cancerDOI 10.1101/2020.12.11.421081Read

Identification and Validation of JAM-A as a Novel Prognostic and Immune Factor in Human TumorsSemantic proximity Read

Aberrant expression of JAM2 inhibits invasion and migration in lung adenocarcinomaSemantic proximity Read

Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastasis via the TGF-β/Smad signal pathwaySemantic proximity Read

JAM‐A expression positively correlates with poor prognosis in breast cancer patientsSemantic proximity Read

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor MicroenvironmentSemantic proximity Read

Identification of biomarker associated with Trop2 in breast cancer: implication for targeted therapySemantic proximity Read

Computational Identification of ECT2 as a Potential Pan-Cancer Biomarker and Therapeutic Target Through Integrated Genomic Data AnalysisSemantic proximity Read

Genome-wide association and functional investigation of M2-like tumor-associated macrophages identified hub genes for breast cancerSemantic proximity Read

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancerSemantic proximity Read

Pan-cancer Analysis Identifies AIMP2 as a Potential Biomarker for Breast CancerSemantic proximity Read

Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition.Semantic proximity Read

Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic driversSemantic proximity Read